Self-management has small effects on pain and disability in people with low back pain, according to a study published online in Arthritis Care & Research.
Self-management has small effects on pain and disability in people with low back pain, according to a study published online in Arthritis Care & Research.
“We found very few trials that tested self-management for low back pain, and in many of the trials we had some concerns about the adequacy of the self-management programs that were tested,” Vinicius Cunha Oliveira, PhD candidate, Arthrithis & Musculoskeletal Research Group, The University of Sydney, Australia, told Formulary. “Acknowledging those limitations, the effects of self-management on pain and disability seemed small, questioning whether or not it is a worthwhile approach.
“There is a growing awareness that low back pain is a long-term condition and that self-management can potentially decrease the burden of this condition,” Oliveira continued. “However, evidence of the effectiveness of self-management of low back pain was unclear.”
Oliveira and colleagues performed a systemic review searching the Medline, Embase, CINAHL, PsycINFO, LILACS, PEDro, AMED, SPORTDIScus, and Cochrane databases from the earliest record to April 2011, that included participants with low back pain of any duration. The researchers included trials in which at least 1 intervention for low back pain was named as “self-management” or “self-care.” Eligible studies were assessed for methodological quality using the PEDro scale, and the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system was used to summarize the strength of the recommendation for each outcome.
The weighted mean difference at short-term follow-up for pain was -3.2 points on a 0–100 scale (95% CI, -5.1, -1.3) and for disability was -2.3 points (95% CI, -3.7, -1.0). The long-term effects were -4.8 (95% CI, -7.1, -2.5) for pain and -2.1 (95% CI, -3.6, -0.6) for disability.
THE FIRST REVIEW
“This was the first review in this area,” he said. “The findings challenge endorsement of self-management for low back pain. Unfortunately, self-management does not help much in low back pain.
“We caution that it would be premature to completely dismiss self-management. We recommend establishing the definition of self-management for low back pain as well as the features of self-management programs by consensus. Research should further understand self-management for low back pain and if specific features may increase its effectiveness.” â
For more on low back pain, go to http://www.ncbi.nlm.nih.gov/pubmed/22623349
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More